Investec Backs Oxford Nanopore with ‘Buy’ Recommendation Amid Health Tech Growth Potential
Oxford Nanopore Technologies PLC has received a ‘buy’ recommendation from Investec, setting a price target of 200 pence, as the company continues to innovate in the health care sector.
- Oxford Nanopore Technologies PLC
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read